HIV, cell therapy
Engineered CAR‑T cells suppressed HIV off medication in two people — promising but early. Larger trials are needed.
Penobscot County is grappling with Maine’s largest HIV outbreak in its history. Looking back, the top public health official for the county seat of Bangor described how the conditions existed for such ...
Barbara Roberts has lived with HIV for more than three decades. Now, a new FDA-approved medication is changing how she ...
More than 200 civil society representatives, people living with HIV and partners gathered in person and online at the United ...
Each time LaTonya looks at framed photos of herself breastfeeding her baby son for the first time, she swells with emotion. As a mother living with HIV in Colorado, it was a moment she wanted to ...
Proposed cuts to global foreign aid, including slashing programs in the United States, could lead to millions of HIV deaths and soaring rates of infections around the world in the coming years, ...
Bianca tells PEOPLE how fear, stigma and evolving guidance shaped her decision to breastfeed her newborn ...
HIV-1 remodels the spatial organization of its co-receptor, CXCR4, on T cell membranes, showing that viral entry requires receptor clustering rather than simple receptor binding.
Dr. Céline Gounder, an internist, epidemiologist and infectious disease specialist, is a CBS News medical correspondent as well as senior fellow and editor-at-large for public health at KFF Health ...
A person with HIV may be more at risk of developing tuberculosis (TB). This is due to the weakening of the immune system that occurs in someone who has HIV. Tuberculosis (TB) is a bacterial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results